A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice

Journal of Experimental Medicine

Volumn 185, Issue 6, 1997, Pages 1013-1021

  Harrison, Leonard C ^a   Honeyman, Margo C ^a   Trembleau, Sylvie ^b   Gregori, Silvia ^b   Gallazzi, Fabio ^b   Augstein, Petra ^a   Brusic, Vladimir ^a   Hammer, Juergen ^b   Adorini, Luciano ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LYSOZYME;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; HYDROPHOBICITY; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PANCREAS INJURY; PANCREAS ISLET; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DIABETES MELLITUS, TYPE 1; EPITOPES; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; HYBRIDOMAS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; PROINSULIN; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0030975684     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.6.1013     Document Type: Article

References (26)

1. Kikutani, H., and S. Makino. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51: 285-322.
2. Liu, G.Y., D. Baker, S. Fairchild, F. Figueroa, R. Quartey-Papafio, M. Tone, D. Healey, A. Cooke, J.L. Turk, and D.C. Wraith. 1993. Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules. Immunogenetics. 37:296-300.
3. Acha-Orbea, H., and H.O. McDevitt. 1987. The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Prof. Natl. Acad. Sci. USA. 84:2435-2439.
4. Tait, B.D., and L.C. Harrison. 1991. Overview: the major histocompatibility complex and insulin-dependent diabetes mellitus. Baillieres Clin. Endocrinol. & Metab. 5:211-228.
5. Rammensee, H.-G. 1995. Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7:85-96.
6. Sinigaglia, F., and J. Hammer. 1994. Defining rules for the peptide-MHC class II interaction. Curr. Opin. Immunol. 6: 52-56.
7. Reich, E.-P., H. von Grafenstein, A. Barlow, K.E. Swendon, K. Williams, and C.A. Janeway, Jr. 1994. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J. Immunol. 152:2279-2288.
8. g7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:450-458.
9. g7) mice share an amino acid motif. J. Immunol. 156:3000-3008.
10. + B cell hybridomas to H-2-restricted T cell hybridomas. Proc. Natl. Acad. Sci. USA. 79:3604-3608.
11. O'Reilly, L.A., P.R. Hutchings, P.R. Crocker, E. Simpson, T. Lund, D. Kioussis, F. Takei, J. Baird, and A. Cooke. 1991. Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur. J. Immunol. 21:1171-1180.
12. nod) islet-derived CD4+ T cell line. Diabetologia. 36:716-721.
13. Adorini, L., A. Sette, S. Buus, H.M. Grey, M. Darsley, P.V. Lehmann, G. Doria, Z.A. Nagy, and E. Appella. 1988. Interaction of an immunodominant epitope with Ia molecules in T-cell activation. Proc. Natl. Acad. Sci. USA. 85:5181-5185.
14. Hurtenbach, U., E. Lier, L. Adorini, and Z.A. Nagy. 1993. Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide. J. Exp. Med. 177:1499-1594.
15. Deng, H., R. Apple, M. Clare-Salzler, S. Trembleau, D. Mathis, L. Adorini, and E. Sercarz. 1993. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 178:1675-1680.
16. Chen, S.-L., P.J. Whiteley, D.C. Freed, J.B. Rothbard, L.B. Peterson, and L.S. Wicker. 1994. Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide. J. Autoimmunity. 7:635-641.
17. Kaufman, D.L., M. Clare-Salzler, J. Tian, T. Forsthuber, G.S.P. Ting, P. Robinson, M.A. Atkinson, E.E. Sercarz, A.J. Tobin, and P.V. Lehmann. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (Lond.). 366:69-72.
18. Smilek, D.E., C.B. Lock, and H.O. McDevitt. 1990. Antigen recognition and peptide-mediated immunotherapy in autoimmune disease. Immunol. Rev. 118:37-71.
19. Vaysburd, M., C. Lock, and H. McDevitt, 1995. Prevention of insulin-dependent diabetes mellitis in nonobese diabetic mice by immunogenic but not by tolerated peptides. J. Exp. Med. 182:897-902.
20. Daniel, D., and D.R. Wegmann. 1996. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA. 93:956-960.
21. Ridgway, W.M., M. Fasso, A. Lanctot, C. Garvey, and C.G. Fathman. 1996. Breaking self-tolerance in nonobese diabetic mice. J. Exp. Med. 183:1657-1662.
22. Bernard, C.C.A., T.G. Johns, A. Slavin, M. Ichikawa, C. Ewing, J. Liu, and J. Bettadapura. 1996. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. In press.
23. d molecules in the activation of MHC class II-restricted T cells. J. Immunol. 147:198-204.
24. Jardetzky, T.S., J.B. Brown, J.C. Gorga, L.J. Stern, R.G. Urban, J.L. Strominger, and D.C. Wiley. 1996. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc. Natl. Acad. Sci. USA. 93:734-738.
25. Rammensee, H.G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:178-228.
26. Hammer, J., F. Gallazzi, E. Bono, R.W. Karr, J. Guenot, P. Valsasnini, Z.A. Nagy, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181:1847-1855.